These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30447029)

  • 1. Harm reduction in opioid treatment: an established idea under threat.
    Kalk NJ
    Addiction; 2019 Jan; 114(1):20-21. PubMed ID: 30447029
    [No Abstract]   [Full Text] [Related]  

  • 2. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid Substitution Therapy: Achieving Harm Reduction While Searching for a Prophylactic Solution.
    Blum K; Baron D
    Curr Pharm Biotechnol; 2019; 20(3):180-182. PubMed ID: 31146660
    [No Abstract]   [Full Text] [Related]  

  • 5. A transitional opioid program to engage hospitalized drug users.
    Shanahan CW; Beers D; Alford DP; Brigandi E; Samet JH
    J Gen Intern Med; 2010 Aug; 25(8):803-8. PubMed ID: 20237960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of opioid use disorder in an innovative community-based setting after multiple treatment attempts in a woman with untreated HIV.
    Voon P; Joe R; Fairgrieve C; Ahamad K
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27402654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
    Trigg BG; Dickman SL
    Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addiction disorders.
    Merrill JO; Duncan MH
    Med Clin North Am; 2014 Sep; 98(5):1097-122. PubMed ID: 25134875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selections of reality: applying Burke's dramatism to a harm reduction program.
    Järvinen M; Miller G
    Int J Drug Policy; 2014 Sep; 25(5):879-87. PubMed ID: 24702965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients.
    Monaghan M; Wincup E
    Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The establishment of a methadone treatment clinic for women in Tehran, Iran.
    Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Mokri A
    J Public Health Policy; 2011 May; 32(2):219-30. PubMed ID: 21390074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From political controversy to a technical problem? Fifteen years of opioid substitution treatment in Finland.
    Selin J; Hakkarainen P; Partanen A; Tammi T; Tigerstedt C
    Int J Drug Policy; 2013 Nov; 24(6):e66-72. PubMed ID: 24095679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for cannabis-based interventions in the opioid overdose crisis.
    Lucas P
    Harm Reduct J; 2017 Aug; 14(1):58. PubMed ID: 28821296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harm Reduction Agencies as a Potential Site for Buprenorphine Treatment.
    Fox AD; Chamberlain A; Frost T; Cunningham CO
    Subst Abus; 2015; 36(2):155-60. PubMed ID: 25837290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trajectory of methadone maintenance treatment in Nepal.
    Ambekar A; Rao R; Pun A; Kumar S; Kishore K
    Int J Drug Policy; 2013 Nov; 24(6):e57-60. PubMed ID: 23845916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Harm reduction interventions in drug users: current situation and recommendations].
    Bosque-Prous M; Brugal MT
    Gac Sanit; 2016 Nov; 30 Suppl 1():99-105. PubMed ID: 27837802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is low threshold methadone maintenance treatment?
    Strike C; Millson M; Hopkins S; Smith C
    Int J Drug Policy; 2013 Nov; 24(6):e51-6. PubMed ID: 23743178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoned Out: "NIMBYism", addiction services and municipal governance in British Columbia.
    Bernstein SE; Bennett D
    Int J Drug Policy; 2013 Nov; 24(6):e61-5. PubMed ID: 23680227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone maintenance-lessons from two systems in China.
    Lee SS; Newman R
    Harm Reduct J; 2017 Sep; 14(1):66. PubMed ID: 28946906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.